Picture of CareDx logo

CDNA — CareDx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

CareDx Inc expected to post a loss of 9 cents a share - Earnings Preview

* CareDx Inc  CDNA.OQ   CDNA.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 27. 
    * The Brisbane California California-based  company is
expected to
report  a 3.1% increase in revenue to $81.66 million from $79.22
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for CareDx Inc is for a
loss
of 9 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CareDx Inc
is
$26.5​, above​ its last closing price of $14.45. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.14       -0.14      -0.06     Beat    57.1
 Jun. 30 2022  -0.11       -0.11      -0.13     Missed  -16.1
 Mar. 31 2022  -0.05       -0.05      -0.13     Missed  -160​
 Dec. 31 2021  0.02        0.03       -0.03     Missed  -192.3
 ​​Sep.        0.01        0.01       0.07      Beat    483.3
 30 2021                                                
 Jun. 30 2021  0.05        0.05       0.11      Beat    111.5​
 Mar. 31 2021  0.02        0.01       0.14      Beat    2,700
 Dec. 31 2020  0.04        0.02       0.08      Beat    272.1
 This summary was machine generated February 25 at 03:03 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on CareDx

See all news